您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Amifampridine phosphate
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Amifampridine phosphate
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Amifampridine phosphate图片
CAS NO:446254-47-3
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
3,4-Diaminopyridine phosphate
产品介绍
Amifampridine (3,4-Diaminopyridine) phosphate 是一种口服有效和可透过细胞的电压门控钾 (Kv) 通道阻断剂 (PCB)。Amifampridine phosphate 对 BoNT/A (HY-P79153) 中毒有明显的逆转作用。Amifampridine phosphate 可增加神经肌肉连接 (NMJs) 的递质释放。Amifampridine phosphate 可用于 Lambert-Eaton 肌无力综合征 (LEMS) 的研究。
生物活性

Amifampridine (3,4-Diaminopyridine) phosphate is an orally active, potent and cell permeablevoltage-gated potassium (Kv) channelblocker (PCB). Amifampridine phosphate is efficacy in the reversal ofBoNT/A(HY-P79153) intoxication. Amifampridine phosphate increases transmitter release from neuromuscular junctions (NMJs). Amifampridine phosphate can be used for Lambert-Eaton myasthenic syndrome (LEMS) research[1][2][3].

体外研究
(In Vitro)

Amifampridine phosphate (1.5 μM) significantly reduces Kv3.3 and Kv3.4 currents by about 10% in HEK293T cells, has no effect on Cav2.1 or Cav1.2 current[3].
Amifampridine phosphate (0-100 μM) increases the duration of the presynaptic AP (action potential) waveform at mammalian and frog NMJs in a dose-dependent manner[3].

体内研究
(In Vivo)

Amifampridine phosphate (Oral gavage; 10 mg/kg; once) can antagonize muscle paralysis following BoNT/A intoxication[2].
Amifampridine phosphate (2.5 mg/kg (IV); 10 mg/kg (PO); once) shows 1 hour plasma half-life and about 57% bioavailability (F) in mice[2].
Amifampridine phosphate has a short plasma half-life and can induce seizures when present at high concentrations, following penetration of the blood-brain barrier[2].

Animal Model:CD-1 mouse (female,25 g, 6 weeks old)[2]
Dosage:10 mg/kg
Administration:Oral gavage, once, after BoNT/A administration (IP)
Result:Revealed that neither LEMs alone (182 ± 43 min) nor the maximum safe orally deliverable dose of 3,4-DAP alone (225 ± 24 min) could significantly increase the time to death following toxin administration (216 ± 29 min). However, when the 10/50/40 3,4-DAP/LEM/shellac formulation was administered at 25 mg/kg the time to death was 302 ± 26 min - a 40% increase as compared to toxin alone.
Animal Model:CD-1 mouse (30-35 g, 8 weeks old)[2]
Dosage:2.5 mg/kg (IV); 10 mg/kg (PO)
Administration:IV, orally, once (Pharmacokinetic Analysis)
Result:Pharmacokinetic Parameters of Amifampridine in CD-1 mouse[1].
IV (2.5 mg/kg)PO (10 mg/kg)
t1/2(h)1.041.28
AUC0-24(μM·h)4.299.72
F (%)10056.7
Clinical Trial
分子量

207.12

Formula

C5H10N3O4P

CAS 号

446254-47-3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.